Among the most serious problems associated with the increasing number of drugs and procedures used in contemporary medical practice is the identification of therapy-associated diseases. This overview of iatrogenic conditions illustrates some adverse reactions produced by chemical, physical, and infectious agents, with emphasis on reactions that were difficult to detect. The advantages and limitations of several procedures for identifying and quantifying iatrogenic conditions are considered from an epidemiologic perspective.
Get full access to this article
View all access options for this article.
References
1.
HolmesO. W.The contagiousness of puerperal fever. New England Quarterly Journal of Medicine and Surgery pp. 1–23, April 1843.
2.
Court-BrownW. M., and DollR.Leukaemia and aplastic anaemia in patients irradiated for ankylosing spondylitis. Medical Research Council. Special Report Series No. 295. Her Majesty's Stationery Office, London, 1957.
3.
StewartA.WebbJ.GilesD., and HewittD.Malignant disease in childhood and diagnostic irradiation in utero. Lancetii: 447, 1956.
4.
MurrayR.HeckelP., and HempelmannL. H.Leukemia in children exposed to ionizing radiation. New Engl. J. Med.261(12): 585–589, 1959.
5.
WarrenS.Longevity and causes of death from irradiatioń in physicians. J.A.M.A.162(5): 464–468, 1956.
6.
SeltserR., and SartwellP. E.The influence of occupational exposure to radiation on the mortality of American radiologists and other medical specialists. Am. J. Epidemiol. 81: 2–22, 1965.
7.
LürmanA.Eine Icterusepidemie. Berliner Klinische Wuchenschrift22: 20–23, 1885.
8.
WadeO. L.Prescribing of chloramphenicol and aplastic anaemia. J. R. Coll. Gen. Pract. 12: 277, 1966.
9.
CampbellK.Intensive oxygen therapy as a possible cause of retrolental fibroplasia: A clinical approach. Med. J. Aust.2: 48–50, 1951.
10.
PatzA.HoeckL. E., and de la CruzE.Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations. Am. J. Ophthalmol. 35: 1248–1253, 1952.
11.
VesseyM. P., and DollR.Investigation of relation between use of oral contraceptives and thromboembolic disease. A further report. Br. Med. J.2: 651–657, 1969.
12.
SartwellP. E.MasiA. T.ArthesG. G.GreeneG. R., and SmithH. E.Thromboembolism and oral contraceptives: An epidemiologic case-control study. Am. J. Epidemiol. 90(5): 365–380, 1969.
13.
KlimtC. R.KnatterudG. L.MeinertC. L., and ProutT. E.A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. I. Design, methods, and baseline results. Diabetes19(suppl. 2): 747–783, 1970.
14.
StolleyP. D.Asthma mortality: Why the United States was spared an epidemic of deaths due to asthma. Am. Rev. Resp. Dis.105: 883–890, 1972.
15.
CluffL. E.ThorntonG.SeidlL. G., and SmithJ. W.Epidemiological study of adverse drug reactions. Trans. Assoc. Am. Physicians78: 255–268, 1965.
16.
SeidlL. G.ThorntonG.SmithJ. W., and CluffL. E.Studies on the epidemiology of adverse reactions. III. Reactions in patients on a general medical service. Bulletin of the Johns Hopkins Hospital119: 299–315, 1966.
17.
JickH.MiettinenO. S.ShapiroS.LewisG. P.SiskindV., and SloneD.Comprehensive drug surveillance. J.A.M.A.213(9): 1455–1460, 1970.
18.
BailarJ. C., and ByarD. P.Estrogen treatment for cancer of the prostate: Early results with three doses of diethylstilbestrol and placebo. Cancer26: 257–261, 1970.
19.
Veterans Administration Cooperative Urological Research Group.Treatment and survival of patients with cancer of the prostate. Surg. Gynecol. Obstet. 124: 1011–1017, 1967.
20.
Coronary Drug Project Research Group.The coronary drug project: Initial findings leading to modification of its research protocol. J.A.M.A.214(7): 1303–1313, 1970.
21.
StolleyP. D.BeckerM. H.McEvillaD. D.LasagnaL.GainorM., and SloaneL. M.Drug prescribing and utilization in an American community. Ann. Intern. Med.76: 537–540, 1972.
22.
HolmesO. W.Currents and counter-currents in medical science. Address delivered before the Annual Meeting of the Massachusetts Medical Society, Boston, May 30, 1860.
